• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of CDRH advisory committee member positions vacant at the end of the month

Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm

Information is current as of December 31, 2014.

Fiscal Year - 2015

Skip graphic and jump to text data

TimeTargetPercent Vacant Positions
Oct 20141018
Nov 20141021
Dec 20141019
Jan 201510TBD
Feb 201510TBD
Mar 201510TBD
Apr 201510TBD
May 201510TBD
Jun 201510TBD
Jul 201510TBD
Aug 201510TBD
Sep 201510TBD

FY 2015 YTD: 19%

Number of CDRH advisory committee member positions vacant at the end of the month

Fiscal Year - 2015
Skip graphic and jump to text data.

TimeTargetVacant Positions
Oct 2014N/A37
Nov 2014N/A43
Dec 2014N/A38
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 38

Total number of CDRH advisory committee member positions at the end of the month

Fiscal Year - 2015
Skip graphic and jump to text data.

TimeTargetPositions
Oct 2014N/A202
Nov 2014N/A202
Dec 2014N/A202
Jan 2015N/ATBD
Feb 2015N/ATBD
Mar 2015N/ATBD
Apr 2015N/ATBD
May 2015N/ATBD
Jun 2015N/ATBD
Jul 2015N/ATBD
Aug 2015N/ATBD
Sep 2015N/ATBD

FY 2015 YTD: 202

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.